 |
PDBsum entry 1quv
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
E.C.2.7.7.48
- RNA-directed Rna polymerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
RNA(n) + a ribonucleoside 5'-triphosphate = RNA(n+1) + diphosphate
|
 |
 |
 |
 |
 |
RNA(n)
|
+
|
ribonucleoside 5'-triphosphate
|
=
|
RNA(n+1)
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.3.4.21.98
- hepacivirin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of four peptide bonds in the viral precursor polyprotein, commonly with Asp or Glu in the P6 position, Cys or Thr in P1 and Ser or Ala in P1'.
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.3.4.22.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
E.C.3.6.1.15
- nucleoside-triphosphate phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a ribonucleoside 5'-triphosphate + H2O = a ribonucleoside 5'-diphosphate + phosphate + H+
|
 |
 |
 |
 |
 |
ribonucleoside 5'-triphosphate
|
+
|
H2O
|
=
|
ribonucleoside 5'-diphosphate
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
E.C.3.6.4.13
- Rna helicase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + H2O = ADP + phosphate + H+
|
 |
 |
 |
 |
 |
ATP
|
+
|
H2O
|
=
|
ADP
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Structure
7:1417-1426
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus.
|
|
H.Ago,
T.Adachi,
A.Yoshida,
M.Yamamoto,
N.Habuka,
K.Yatsunami,
M.Miyano.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Hepatitis C virus (HCV) is the major etiological agent of
hepatocellular carcinoma, and HCV RNA-dependent RNA polymerase (RdRp) is one of
the main potential targets for anti-HCV agents. HCV RdRp performs run-off
copying replication in an RNA-selective manner for the template-primer duplex
and the substrate, but the structural basis of this reaction mechanism has still
to be elucidated. RESULTS: The three-dimensional structure of HCV RdRp was
determined by X-ray crystallography at 2.5 A resolution. The compact HCV RdRp
structure resembles a right hand, but has more complicated fingers and thumb
domains than those of the other known polymerases, with a novel alpha-helix-rich
subdomain (alpha fingers) as an addition to the fingers domain. The other
fingers subdomain (beta fingers) is folded in the same manner as the fingers
domain of human immunodeficiency virus (HIV) reverse transcriptase (RT), another
RNA-dependent polymerase. The ribose-recognition site of HCV RdRp is constructed
of hydrophilic residues, unlike those of DNA polymerases. The C-terminal region
of HCV RdRp occupies the putative RNA-duplex-binding cleft. CONCLUSIONS: The
structural basis of the RNA selectivity of HCV RdRp was elucidated from its
crystal structure. The putative substrate-binding site with a shallow
hydrophilic cavity should have ribonucleoside triphosphate (rNTP) as the
preferred substrate. We propose that the unique alpha fingers might represent a
common structural discriminator of the template-primer duplex that distinguishes
between RNA and DNA during the replication of positive single-stranded RNA by
viral RdRps. The C-terminal region might exert a regulatory function on the
initiation and activity of HCV RdRp.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 3.
Figure 3. Structure comparison of HCV RdRp with poliovirus
RdRp and HIV RT and with the Mrf-2 DNA-binding domain. (a)
Stereoview of superimposed wire models of the a- and b-fingers
subdomains and palm domain of HCV RdRp and the corresponding
portions of poliovirus RdRp [13] and the ternary complex of HIV
RT [24]. The a fingers, b fingers, and palm of HCV RdRp are
shown in green, cyan, and pink, respectively. Poliovirus RdRp is
shown in silver and HIV RT is shown in gold. The positively
charged residues mentioned in the text are represented by blue
balls and sticks. In the b-fingers subdomain, the basic residues
are Lys51, Arg48, Arg158, Lys155 and Lys141 from the outside. In
the a fingers, the residues are Lys98, Arg168, Lys172, Lys90,
Arg109 and Lys106 from the top right in a clockwise direction.
(b) Stereoview of superimposed wire models of the thumb domains
of HCV RdRp (violet), poliovirus RdRp (silver) [13] and HIV RT
(gold) [24]. (c) Stereoview of superimposed wire models of the
a-fingers region, including its connecting b1-b2 loop in the
b-fingers subdomain (residues 74-189), of HCV RdRp (blue) and
the Mrf-2 DNA-binding domain (red) [25].
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from Cell Press:
Structure
(1999,
7,
1417-1426)
copyright 1999.
|
|
| |
Figure was
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
H.R.Park,
K.S.Park,
and
Y.Chong
(2011).
2-Arylmethylaminomethyl-5,6-dihydroxychromone derivatives with selective anti-HCV activity.
|
| |
Bioorg Med Chem Lett,
21,
3202-3205.
|
 |
|
|
|
|
 |
C.Roh,
H.Y.Lee,
S.E.Kim,
and
S.K.Jo
(2010).
A highly sensitive and selective viral protein detection method based on RNA oligonucleotide nanoparticle.
|
| |
Int J Nanomedicine,
5,
323-329.
|
 |
|
|
|
|
 |
H.Tang,
and
H.Grisé
(2009).
Cellular and molecular biology of HCV infection and hepatitis.
|
| |
Clin Sci (Lond),
117,
49-65.
|
 |
|
|
|
|
 |
L.Weng,
J.Du,
J.Zhou,
J.Ding,
T.Wakita,
M.Kohara,
and
T.Toyoda
(2009).
Modification of hepatitis C virus 1b RNA polymerase to make a highly active JFH1-type polymerase by mutation of the thumb domain.
|
| |
Arch Virol,
154,
765-773.
|
 |
|
|
|
|
 |
M.Issur,
B.J.Geiss,
I.Bougie,
F.Picard-Jean,
S.Despins,
J.Mayette,
S.E.Hobdey,
and
M.Bisaillon
(2009).
The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure.
|
| |
RNA,
15,
2340-2350.
|
 |
|
|
|
|
 |
P.Simister,
M.Schmitt,
M.Geitmann,
O.Wicht,
U.H.Danielson,
R.Klein,
S.Bressanelli,
and
V.Lohmann
(2009).
Structural and functional analysis of hepatitis C virus strain JFH1 polymerase.
|
| |
J Virol,
83,
11926-11939.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.M.McDonald,
Y.J.Tao,
and
J.T.Patton
(2009).
The ins and outs of four-tunneled Reoviridae RNA-dependent RNA polymerases.
|
| |
Curr Opin Struct Biol,
19,
775-782.
|
 |
|
|
|
|
 |
Z.Liu,
J.M.Robida,
S.Chinnaswamy,
G.Yi,
J.M.Robotham,
H.B.Nelson,
A.Irsigler,
C.C.Kao,
and
H.Tang
(2009).
Mutations in the hepatitis C virus polymerase that increase RNA binding can confer resistance to cyclosporine A.
|
| |
Hepatology,
50,
25-33.
|
 |
|
|
|
|
 |
A.Abrahem,
and
M.Pelchat
(2008).
Formation of an RNA polymerase II preinitiation complex on an RNA promoter derived from the hepatitis delta virus RNA genome.
|
| |
Nucleic Acids Res,
36,
5201-5211.
|
 |
|
|
|
|
 |
A.Nikonov,
E.Juronen,
and
M.Ustav
(2008).
Functional characterization of fingers subdomain-specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase.
|
| |
J Biol Chem,
283,
24089-24102.
|
 |
|
|
|
|
 |
A.Shatkin,
K.Das,
and
E.Arnold
(2008).
3D jigsaw puzzle in rotavirus assembly.
|
| |
Structure,
16,
1601-1602.
|
 |
|
|
|
|
 |
E.V.Koonin,
Y.I.Wolf,
K.Nagasaki,
and
V.V.Dolja
(2008).
The Big Bang of picorna-like virus evolution antedates the radiation of eukaryotic supergroups.
|
| |
Nat Rev Microbiol,
6,
925-939.
|
 |
|
|
|
|
 |
K.J.Herlihy,
J.P.Graham,
R.Kumpf,
A.K.Patick,
R.Duggal,
and
S.T.Shi
(2008).
Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors.
|
| |
Antimicrob Agents Chemother,
52,
3523-3531.
|
 |
|
|
|
|
 |
K.K.Ng,
J.J.Arnold,
and
C.E.Cameron
(2008).
Structure-function relationships among RNA-dependent RNA polymerases.
|
| |
Curr Top Microbiol Immunol,
320,
137-156.
|
 |
|
|
|
|
 |
M.Hass,
M.Lelke,
C.Busch,
B.Becker-Ziaja,
and
S.Günther
(2008).
Mutational evidence for a structural model of the Lassa virus RNA polymerase domain and identification of two residues, Gly1394 and Asp1395, that are critical for transcription but not replication of the genome.
|
| |
J Virol,
82,
10207-10217.
|
 |
|
|
|
|
 |
N.Kaushik-Basu,
A.Bopda-Waffo,
T.T.Talele,
A.Basu,
P.R.Costa,
A.J.da Silva,
S.G.Sarafianos,
and
F.Noël
(2008).
Identification and characterization of coumestans as novel HCV NS5B polymerase inhibitors.
|
| |
Nucleic Acids Res,
36,
1482-1496.
|
 |
|
|
|
|
 |
P.Bellecave,
C.Cazenave,
J.Rumi,
C.Staedel,
O.Cosnefroy,
M.L.Andreola,
M.Ventura,
L.Tarrago-Litvak,
and
T.Astier-Gin
(2008).
Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells.
|
| |
Antimicrob Agents Chemother,
52,
2097-2110.
|
 |
|
|
|
|
 |
A.A.Thompson,
R.A.Albertini,
and
O.B.Peersen
(2007).
Stabilization of poliovirus polymerase by NTP binding and fingers-thumb interactions.
|
| |
J Mol Biol,
366,
1459-1474.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Malet,
M.P.Egloff,
B.Selisko,
R.E.Butcher,
P.J.Wright,
M.Roberts,
A.Gruez,
G.Sulzenbacher,
C.Vonrhein,
G.Bricogne,
J.M.Mackenzie,
A.A.Khromykh,
A.D.Davidson,
and
B.Canard
(2007).
Crystal structure of the RNA polymerase domain of the West Nile virus non-structural protein 5.
|
| |
J Biol Chem,
282,
10678-10689.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Deval,
C.M.D'Abramo,
Z.Zhao,
S.McCormick,
D.Coutsinos,
S.Hess,
M.Kvaratskhelia,
and
M.Götte
(2007).
High resolution footprinting of the hepatitis C virus polymerase NS5B in complex with RNA.
|
| |
J Biol Chem,
282,
16907-16916.
|
 |
|
|
|
|
 |
J.M.Pawlotsky,
S.Chevaliez,
and
J.G.McHutchison
(2007).
The hepatitis C virus life cycle as a target for new antiviral therapies.
|
| |
Gastroenterology,
132,
1979-1998.
|
 |
|
|
|
|
 |
J.M.Robida,
H.B.Nelson,
Z.Liu,
and
H.Tang
(2007).
Characterization of hepatitis C virus subgenomic replicon resistance to cyclosporine in vitro.
|
| |
J Virol,
81,
5829-5840.
|
 |
|
|
|
|
 |
L.L.Marcotte,
A.B.Wass,
D.W.Gohara,
H.B.Pathak,
J.J.Arnold,
D.J.Filman,
C.E.Cameron,
and
J.M.Hogle
(2007).
Crystal structure of poliovirus 3CD protein: virally encoded protease and precursor to the RNA-dependent RNA polymerase.
|
| |
J Virol,
81,
3583-3596.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.S.Freistadt,
and
K.E.Eberle
(2007).
Conserved aspartic acid 233 and alanine 231 are not required for poliovirus polymerase function in replicons.
|
| |
Virol J,
4,
28.
|
 |
|
|
|
|
 |
R.De Francesco,
and
A.Carfí
(2007).
Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus.
|
| |
Adv Drug Deliv Rev,
59,
1242-1262.
|
 |
|
|
|
|
 |
S.K.Panda,
D.Thakral,
and
S.Rehman
(2007).
Hepatitis E virus.
|
| |
Rev Med Virol,
17,
151-180.
|
 |
|
|
|
|
 |
T.L.Yap,
T.Xu,
Y.L.Chen,
H.Malet,
M.P.Egloff,
B.Canard,
S.G.Vasudevan,
and
J.Lescar
(2007).
Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution.
|
| |
J Virol,
81,
4753-4765.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Suzuki,
K.Ishii,
H.Aizaki,
and
T.Wakita
(2007).
Hepatitis C viral life cycle.
|
| |
Adv Drug Deliv Rev,
59,
1200-1212.
|
 |
|
|
|
|
 |
A.Y.Howe,
H.Cheng,
I.Thompson,
S.K.Chunduru,
S.Herrmann,
J.O'Connell,
A.Agarwal,
R.Chopra,
and
A.M.Del Vecchio
(2006).
Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase inhibitor.
|
| |
Antimicrob Agents Chemother,
50,
4103-4113.
|
 |
|
|
|
|
 |
C.M.D'Abramo,
J.Deval,
C.E.Cameron,
L.Cellai,
and
M.Götte
(2006).
Control of template positioning during de novo initiation of RNA synthesis by the bovine viral diarrhea virus NS5B polymerase.
|
| |
J Biol Chem,
281,
24991-24998.
|
 |
|
|
|
|
 |
E.V.Koonin,
T.G.Senkevich,
and
V.V.Dolja
(2006).
The ancient Virus World and evolution of cells.
|
| |
Biol Direct,
1,
29.
|
 |
|
|
|
|
 |
J.Ortín,
and
F.Parra
(2006).
Structure and function of RNA replication.
|
| |
Annu Rev Microbiol,
60,
305-326.
|
 |
|
|
|
|
 |
K.H.Choi,
A.Gallei,
P.Becher,
and
M.G.Rossmann
(2006).
The structure of bovine viral diarrhea virus RNA-dependent RNA polymerase and its amino-terminal domain.
|
| |
Structure,
14,
1107-1113.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.A.Jones,
L.E.Clancy,
W.D.Rawlinson,
and
P.A.White
(2006).
High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity.
|
| |
Antimicrob Agents Chemother,
50,
3019-3027.
|
 |
|
|
|
|
 |
A.D.Kwong,
B.G.Rao,
and
K.T.Jeang
(2005).
Viral and cellular RNA helicases as antiviral targets.
|
| |
Nat Rev Drug Discov,
4,
845-853.
|
 |
|
|
|
|
 |
B.K.Biswal,
M.M.Cherney,
M.Wang,
L.Chan,
C.G.Yannopoulos,
D.Bilimoria,
O.Nicolas,
J.Bedard,
and
M.N.James
(2005).
Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors.
|
| |
J Biol Chem,
280,
18202-18210.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.Ferron,
C.Bussetta,
H.Dutartre,
and
B.Canard
(2005).
The modeled structure of the RNA dependent RNA polymerase of GBV-C virus suggests a role for motif E in Flaviviridae RNA polymerases.
|
| |
BMC Bioinformatics,
6,
255.
|
 |
|
|
|
|
 |
G.Kukolj,
G.A.McGibbon,
G.McKercher,
M.Marquis,
S.Lefèbvre,
L.Thauvette,
J.Gauthier,
S.Goulet,
M.A.Poupart,
and
P.L.Beaulieu
(2005).
Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase.
|
| |
J Biol Chem,
280,
39260-39267.
|
 |
|
|
|
|
 |
K.Watanabe,
K.Yoshioka,
M.Yano,
M.Ishigami,
K.Ukai,
H.Ito,
F.Miyata,
T.Mizutani,
and
H.Goto
(2005).
Mutations in the nonstructural region 5B of hepatitis C virus genotype 1b: their relation to viral load, response to interferon, and the nonstructural region 5A.
|
| |
J Med Virol,
75,
504-512.
|
 |
|
|
|
|
 |
R.De Francesco,
and
G.Migliaccio
(2005).
Challenges and successes in developing new therapies for hepatitis C.
|
| |
Nature,
436,
953-960.
|
 |
|
|
|
|
 |
S.Di Marco,
C.Volpari,
L.Tomei,
S.Altamura,
S.Harper,
F.Narjes,
U.Koch,
M.Rowley,
R.De Francesco,
G.Migliaccio,
and
A.Carfí
(2005).
Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site.
|
| |
J Biol Chem,
280,
29765-29770.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.C.Appleby,
H.Luecke,
J.H.Shim,
J.Z.Wu,
I.W.Cheney,
W.Zhong,
L.Vogeley,
Z.Hong,
and
N.Yao
(2005).
Crystal structure of complete rhinovirus RNA polymerase suggests front loading of protein primer.
|
| |
J Virol,
79,
277-288.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.C.Kim,
W.K.Russell,
C.T.Ranjith-Kumar,
M.Thomson,
D.H.Russell,
and
C.C.Kao
(2005).
Functional analysis of RNA binding by the hepatitis C virus RNA-dependent RNA polymerase.
|
| |
J Biol Chem,
280,
38011-38019.
|
 |
|
|
|
|
 |
Z.Cai,
M.Yi,
C.Zhang,
and
G.Luo
(2005).
Mutagenesis analysis of the rGTP-specific binding site of hepatitis C virus RNA-dependent RNA polymerase.
|
| |
J Virol,
79,
11607-11617.
|
 |
|
|
|
|
 |
C.Ferrer-Orta,
A.Arias,
R.Perez-Luque,
C.Escarmís,
E.Domingo,
and
N.Verdaguer
(2004).
Structure of foot-and-mouth disease virus RNA-dependent RNA polymerase and its complex with a template-primer RNA.
|
| |
J Biol Chem,
279,
47212-47221.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Liu,
R.Chopra,
S.Swanberg,
S.Olland,
J.O'Connell,
and
S.Herrmann
(2004).
Elongation of synthetic RNA templates by hepatitis C virus NS5B polymerase.
|
| |
J Biol Chem,
279,
10738-10746.
|
 |
|
|
|
|
 |
D.R.Hwang,
Y.C.Tsai,
J.C.Lee,
K.K.Huang,
R.K.Lin,
C.H.Ho,
J.M.Chiou,
Y.T.Lin,
J.T.Hsu,
and
C.T.Yeh
(2004).
Inhibition of hepatitis C virus replication by arsenic trioxide.
|
| |
Antimicrob Agents Chemother,
48,
2876-2882.
|
 |
|
|
|
|
 |
K.H.Choi,
J.M.Groarke,
D.C.Young,
M.G.Rossmann,
D.C.Pevear,
R.J.Kuhn,
and
J.L.Smith
(2004).
Design, expression, and purification of a Flaviviridae polymerase using a high-throughput approach to facilitate crystal structure determination.
|
| |
Protein Sci,
13,
2685-2692.
|
 |
|
|
|
|
 |
K.K.Ng,
N.Pendás-Franco,
J.Rojo,
J.A.Boga,
A.Machín,
J.M.Alonso,
and
F.Parra
(2004).
Crystal structure of norwalk virus polymerase reveals the carboxyl terminus in the active site cleft.
|
| |
J Biol Chem,
279,
16638-16645.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Kumagai,
N.Takahashi,
M.Kinoshita,
S.Tsunematsu,
K.Tsuchimoto,
H.Saito,
and
H.Ishii
(2004).
Polymorphisms of NS5B protein relates to early clearance of hepatitis C virus by interferon plus ribavirin: a pilot study.
|
| |
J Viral Hepat,
11,
225-235.
|
 |
|
|
|
|
 |
P.S.Salgado,
E.V.Makeyev,
S.J.Butcher,
D.H.Bamford,
D.I.Stuart,
and
J.M.Grimes
(2004).
The structural basis for RNA specificity and Ca2+ inhibition of an RNA-dependent RNA polymerase.
|
| |
Structure,
12,
307-316.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.A.Love,
K.A.Maegley,
X.Yu,
R.A.Ferre,
L.K.Lingardo,
W.Diehl,
H.E.Parge,
P.S.Dragovich,
and
S.A.Fuhrman
(2004).
The crystal structure of the RNA-dependent RNA polymerase from human rhinovirus: a dual function target for common cold antiviral therapy.
|
| |
Structure,
12,
1533-1544.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.J.Kim,
J.H.Kim,
Y.G.Kim,
H.S.Lim,
and
J.W.Oh
(2004).
Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation.
|
| |
J Biol Chem,
279,
50031-50041.
|
 |
|
|
|
|
 |
Y.Ma,
T.Shimakami,
H.Luo,
N.Hayashi,
and
S.Murakami
(2004).
Mutational Analysis of Hepatitis C Virus NS5B in the Subgenomic Replicon Cell Culture.
|
| |
J Biol Chem,
279,
25474-25482.
|
 |
|
|
|
|
 |
I.Bougie,
and
M.Bisaillon
(2003).
Initial binding of the broad spectrum antiviral nucleoside ribavirin to the hepatitis C virus RNA polymerase.
|
| |
J Biol Chem,
278,
52471-52478.
|
 |
|
|
|
|
 |
I.Bougie,
S.Charpentier,
and
M.Bisaillon
(2003).
Characterization of the metal ion binding properties of the hepatitis C virus RNA polymerase.
|
| |
J Biol Chem,
278,
3868-3875.
|
 |
|
|
|
|
 |
K.C.Young,
K.L.Lindsay,
K.J.Lee,
W.C.Liu,
J.W.He,
S.L.Milstein,
and
M.M.Lai
(2003).
Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy.
|
| |
Hepatology,
38,
869-878.
|
 |
|
|
|
|
 |
M.Hirano,
S.Kaneko,
T.Yamashita,
H.Luo,
W.Qin,
Y.Shirota,
T.Nomura,
K.Kobayashi,
and
S.Murakami
(2003).
Direct interaction between nucleolin and hepatitis C virus NS5B.
|
| |
J Biol Chem,
278,
5109-5115.
|
 |
|
|
|
|
 |
M.Wang,
K.K.Ng,
M.M.Cherney,
L.Chan,
C.G.Yannopoulos,
J.Bedard,
N.Morin,
N.Nguyen-Ba,
M.H.Alaoui-Ismaili,
R.C.Bethell,
and
M.N.James
(2003).
Non-nucleoside analogue inhibitors bind to an allosteric site on HCV NS5B polymerase. Crystal structures and mechanism of inhibition.
|
| |
J Biol Chem,
278,
9489-9495.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Bellecave,
M.L.Andreola,
M.Ventura,
L.Tarrago-Litvak,
S.Litvak,
and
T.Astier-Gin
(2003).
Selection of DNA aptamers that bind the RNA-dependent RNA polymerase of hepatitis C virus and inhibit viral RNA synthesis in vitro.
|
| |
Oligonucleotides,
13,
455-463.
|
 |
|
|
|
|
 |
R.A.Love,
H.E.Parge,
X.Yu,
M.J.Hickey,
W.Diehl,
J.Gao,
H.Wriggers,
A.Ekker,
L.Wang,
J.A.Thomson,
P.S.Dragovich,
and
S.A.Fuhrman
(2003).
Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme.
|
| |
J Virol,
77,
7575-7581.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.Xu,
Y.Liu,
S.Weiss,
E.Arnold,
S.G.Sarafianos,
and
J.Ding
(2003).
Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug design.
|
| |
Nucleic Acids Res,
31,
7117-7130.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Biroccio,
J.Hamm,
I.Incitti,
R.De Francesco,
and
L.Tomei
(2002).
Selection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymerase.
|
| |
J Virol,
76,
3688-3696.
|
 |
|
|
|
|
 |
D.Moradpour,
E.Bieck,
T.Hügle,
W.Wels,
J.Z.Wu,
Z.Hong,
H.E.Blum,
and
R.Bartenschlager
(2002).
Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase.
|
| |
J Biol Chem,
277,
593-601.
|
 |
|
|
|
|
 |
M.R.Laurila,
E.V.Makeyev,
and
D.H.Bamford
(2002).
Bacteriophage phi 6 RNA-dependent RNA polymerase: molecular details of initiating nucleic acid synthesis without primer.
|
| |
J Biol Chem,
277,
17117-17124.
|
 |
|
|
|
|
 |
S.Bressanelli,
L.Tomei,
F.A.Rey,
and
R.De Francesco
(2002).
Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides.
|
| |
J Virol,
76,
3482-3492.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Piccininni,
A.Varaklioti,
M.Nardelli,
B.Dave,
K.D.Raney,
and
J.E.McCarthy
(2002).
Modulation of the hepatitis C virus RNA-dependent RNA polymerase activity by the non-structural (NS) 3 helicase and the NS4B membrane protein.
|
| |
J Biol Chem,
277,
45670-45679.
|
 |
|
|
|
|
 |
B.W.Dymock
(2001).
Emerging therapies for hepatitis C virus infection.
|
| |
Expert Opin Emerg Drugs,
6,
13-42.
|
 |
|
|
|
|
 |
J.Schmidt-Mende,
E.Bieck,
T.Hugle,
F.Penin,
C.M.Rice,
H.E.Blum,
and
D.Moradpour
(2001).
Determinants for membrane association of the hepatitis C virus RNA-dependent RNA polymerase.
|
| |
J Biol Chem,
276,
44052-44063.
|
 |
|
|
|
|
 |
S.Reigadas,
M.Ventura,
L.Sarih-Cottin,
M.Castroviejo,
S.Litvak,
and
T.Astier-Gin
(2001).
HCV RNA-dependent RNA polymerase replicates in vitro the 3' terminal region of the minus-strand viral RNA more efficiently than the 3' terminal region of the plus RNA.
|
| |
Eur J Biochem,
268,
5857-5867.
|
 |
|
|
|
|
 |
X.Lin,
Z.H.Yuan,
L.Wu,
J.P.Ding,
and
Y.M.Wen
(2001).
A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency.
|
| |
J Virol,
75,
11827-11833.
|
 |
|
|
|
|
 |
S.G.Baginski,
D.C.Pevear,
M.Seipel,
S.C.Sun,
C.A.Benetatos,
S.K.Chunduru,
C.M.Rice,
and
M.S.Collett
(2000).
Mechanism of action of a pestivirus antiviral compound.
|
| |
Proc Natl Acad Sci U S A,
97,
7981-7986.
|
 |
|
|
|
|
 |
W.Zhong,
E.Ferrari,
C.A.Lesburg,
D.Maag,
S.K.Ghosh,
C.E.Cameron,
J.Y.Lau,
and
Z.Hong
(2000).
Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase.
|
| |
J Virol,
74,
9134-9143.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |